Scientists used a mobile app to screen elderly patients for potential skin cancer lesions, pointing to the value of digital health tools.
Researchers at Stanford Medicine discover a certain molecule renders a type of cancer cell more susceptible to treatment.
While melanoma rates have leveled off for most of the United States, Black and Latino communities are at a higher risk for the disease.
Stanford Medicine resident and collaborators spearhead an effort to decrease waste from dermatology clinics.
A Stanford doctor traveled to Poland to help pediatric cancer patients evacuate from Ukraine and receive care.
Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
From the genetics of COVID-19, to cancer, to tonsils, this story is a wrap up of Scope's most read stories of 2021.
Neurosurgeon Michael Lim studies how to unleash the immune system to attack a type of brain cancer called glioblastoma.
A common ovarian cancer evades detection by convincing nearby immune cells to treat it as a developing fetus.
Stanford Medicine researchers conducted an experiment to find new genes that, when knocked out, boost immune cells' cancer-killing ability.
Stanford Medicine Scientists have devised a blood test to predict some cancer relapses after patients have already been treated.
A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Induced pluripotent stem cells share proteins with some cancers. The cells can be used as a vaccine to prevent pancreatic cancers in mice.
As risk factors such as no health insurance and low income accumulate, colorectal cancer patients are less likely to finish chemotherapy.
